儿童神经病学器械市场规模、份额和增长分析（按产品、服务/手术、神经病学专科、年龄组、最终用户、应用和地区划分）—2026-2033年行业预测

预计到 2024 年，儿童神经科设备市场规模将达到 39.6 亿美元，到 2025 年将达到 42.3 亿美元，到 2033 年将达到 72.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 6.9%。

全球儿童神经系统疾病发生率的不断上升，推动了对儿童神经科设备的需求。创伤、神经毒素暴露、疾病和遗传易感性等因素，导致低风险和高风险神经系统疾病的诊断数量显着增加。癫痫发作尤其常见于这些疾病中，凸显了针对儿童独特神经功能而客製化的专用设备的必要性。对神经系统疾病监测的日益重视，推动了神经科设备的创新，以减轻这些疾病的负担。此外，包括机器学习和人工智慧在内的医疗技术进步，有望改变儿童神经科设备市场。各国政府和医疗机构为提高公众对儿童神经系统疾病的认识所做的努力，也有望促进设备销售的成长。

儿童神经病学器材市场驱动因素

各年龄层对神经系统疾病的日益关注正显着影响着儿童神经科医疗器材市场。这种意识提升源自于该疾病发病率的上升以及众多旨在普及相关知识的全球性宣传活动。此外，神经系统疾病死亡率的惊人成长也进一步推动了对儿童神经科医疗器材的需求。随着越来越多人认识到神经系统疾病的挑战和影响，人们越来越意识到需要为患有这些疾病的儿童提供有效的医疗解决方案，从而推动了市场成长。

儿童神经科器械市场面临的限制

由于治疗神经系统疾病的高昂费用，儿童神经科设备市场面临巨大的限制。这些治疗所需的精密设备不仅购置成本高昂，维护和营运成本也同样庞大。此外，由于这些设备是专为儿童患者设计的，其适用范围有限，进一步加重了家庭的经济负担。因此，神经系统疾病治疗的总费用高得令人望而却步，阻碍了潜在患者接受必要的治疗，最终影响了市场成长和可近性。

儿童神经病学器材市场趋势

由于旨在提高儿童神经系统疾病诊断准确性的医疗技术不断进步，儿童神经科设备市场正经历显着增长。在对诊断准确性日益增长的需求驱动下，製造商正加速将人工智慧、先进医学影像和机器学习等先进技术整合到其设备中。这一趋势不仅有助于提高诊断准确性，而且为创新治疗方案和改善患者预后铺平了道路。因此，儿童神经科设备供应商已做好充分准备，把握这一不断变化的市场机会，稳步迈向更有效诊断和治疗儿童神经系统疾病的目标。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球儿童神经病学器材市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 神经外科器械
• 神经刺激设备
• 脑脊髓液（CSF）管理装置
• 其他的

全球儿童神经病学器械市场规模（按服务和疗法划分）及复合年增长率（2026-2033 年）

• 脑电图（EEG）
• 鞘内注射Baclofen疗法
• 神经系统评估
• 迷走神经刺激

全球儿童神经病学器材市场规模（依神经科专科划分）及复合年增长率（2026-2033 年）

• 神经肿瘤学
• 神经肌肉疾病
• 新生儿神经病学
• 神经免疫学
• 中风

全球儿童神经学器材市场规模（按年龄组别划分）及复合年增长率（2026-2033 年）

• 新生
• 婴儿
• 儿童
• 青春期

全球儿童神经病学设备市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

• 医院
• 医疗中心
• 专科诊所
• 神经研究中心

全球儿童神经学器材市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 脑肿瘤
• 癫痫
• 泛自闭症障碍
• 帕金森氏症
• 其他的

全球儿童神经学器材市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Medtronic plc（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Johnson & Johnson（USA）
• LivaNova PLC（UK）
• Integra LifeSciences（USA）
• Natus Medical Incorporated（USA）
• Nihon Kohden Corporation（Japan）
• B. Braun Melsungen AG（Germany）
• Stryker Corporation（USA）
• Siemens Healthineers AG（Germany）
• Philips Healthcare（Netherlands）
• Computational Diagnostics, Inc.（USA）
• Elekta AB（Sweden）
• NeuroPace, Inc.（USA）
• Terumo Corporation（Japan）
• Smith+Nephew（UK）
• Mizuho OSI（USA）
• Orpyx Medical Technologies Inc.（Canada）
• Magstim（UK）

结论与建议

Pediatric Neurology Device Market size was valued at USD 3.96 Billion in 2024 and is poised to grow from USD 4.23 Billion in 2025 to USD 7.21 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The increasing incidence of neurological disorders in children globally is driving the demand for pediatric neurology devices. A rise in diagnoses of both low-risk and high-risk neurological conditions, influenced by factors such as injuries, exposure to neurotoxins, diseases, or genetic predispositions, is notable. Seizures are particularly prevalent among these disorders, highlighting the need for specialized devices tailored to children's unique neurological functions. A heightened emphasis on neurological research aims to alleviate the burden of these disorders, fostering innovation in neurology devices. Furthermore, advancements in healthcare technology, including machine learning and artificial intelligence, are set to transform the pediatric neurology device market. Initiatives from governments and health organizations to raise awareness about pediatric neurological issues are also expected to enhance device sales.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pediatric Neurology Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pediatric Neurology Device Market Segments Analysis

Global Pediatric Neurology Device Market is segmented by Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application and region. Based on Product, the market is segmented into Neurosurgery Devices, Neurostimulator, Cerebrospinal Fluid (CSF) Management Devices and Other. Based on Service and Treatment, the market is segmented into Electroencephalogram, Intrathecal Baclofen Therapy, Neurological Evaluations and Vagal Nerve Stimulation. Based on Neurological Specialty, the market is segmented into Neuro-Oncology, Neuromuscular, Neonatal Neurology, Neuro-Immunology and Stroke. Based on Age Group, the market is segmented into Neonates, Infants, Children and Adolescents. Based on End User, the market is segmented into Hospital, Healthcare Center, Specialty Clinics and Neurological Research Centres. Based on Application, the market is segmented into Brain Tumour, Epilepsy, Autism Spectrum Disorder, Parkinson's Disease and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pediatric Neurology Device Market

The growing awareness of neurological disorders across various age groups is significantly influencing the Pediatric Neurology Device market. This heightened consciousness results from the rising incidence of these disorders and the introduction of numerous global awareness campaigns aimed at educating the public. Additionally, the alarming increase in mortality rates associated with neurological conditions is further driving the demand for pediatric neurology devices. As more individuals become informed about the challenges and impacts of neurological diseases, the need for effective medical solutions for children experiencing these conditions is increasingly recognized, thereby propelling market growth.

Restraints in the Pediatric Neurology Device Market

The Pediatric Neurology Device market faces significant constraints due to the high costs associated with treating neurological disorders. The advanced devices essential for these treatments are not only expensive to acquire but also costly to maintain and operate. Additionally, since these devices are specifically tailored for pediatric patients, their application remains limited, further exacerbating the financial burden on families. As a result, the overall expenses related to neurological treatment can be quite daunting, deterring potential patients from pursuing necessary care and ultimately impacting market growth and accessibility.

Market Trends of the Pediatric Neurology Device Market

The Pediatric Neurology Device market is experiencing significant growth driven by advancements in healthcare technology aimed at enhancing the diagnosis of neurological conditions in children. With a rising demand for precision in diagnosis, manufacturers are increasingly integrating sophisticated technologies such as artificial intelligence, advanced medical imaging, and machine learning into their devices. This trend not only facilitates higher diagnostic accuracy but also opens doors to innovative therapeutic solutions and improved patient outcomes. As a result, pediatric neurology device suppliers are well-positioned to capitalize on this evolving landscape, making strides towards more effective diagnosis and management of neurological disorders in the pediatric population.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Pediatric Neurology Device Market Size by Product & CAGR (2026-2033)

• Market Overview
• Neurosurgery Devices
• Neurostimulator
• Cerebrospinal Fluid (CSF) Management Devices
• Other

Global Pediatric Neurology Device Market Size by Service and Treatment & CAGR (2026-2033)

• Market Overview
• Electroencephalogram
• Intrathecal Baclofen Therapy
• Neurological Evaluations
• Vagal Nerve Stimulation

Global Pediatric Neurology Device Market Size by Neurological Specialty & CAGR (2026-2033)

• Market Overview
• Neuro-Oncology
• Neuromuscular
• Neonatal Neurology
• Neuro-Immunology
• Stroke

Global Pediatric Neurology Device Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Neonates
• Infants
• Children
• Adolescents

Global Pediatric Neurology Device Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospital
• Healthcare Center
• Specialty Clinics
• Neurological Research Centres

Global Pediatric Neurology Device Market Size by Application & CAGR (2026-2033)

• Market Overview
• Brain Tumour
• Epilepsy
• Autism Spectrum Disorder
• Parkinson's Disease
• Others

Global Pediatric Neurology Device Market Size & CAGR (2026-2033)

• North America (Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application)
  • US
  • Canada
• Europe (Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Service and Treatment, Neurological Specialty, Age Group, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Computational Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith+Nephew (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mizuho OSI (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orpyx Medical Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Magstim (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations